Moreover, recent reports have revealed that a neutralizing antibody that selectively blocks the interaction of FGF19 with FGFR4 inhibits the growth of colon tumors and the formation of liver tumors in vivo [28]. The gene discussed is FGF19; the disease is colonic neoplasm.